Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Macklin

Showing results (151-160 of 191) with videos related to

Pageof 20
Sort By:
Ebiomedicine|September 13, 2024
Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysisMichael Benatar, Eric A Macklin, Andrea Malaspina, et al.
Brain, Behavior, and Immunity|May 17, 2016
Associations between cytokines, endocrine stress response, and gastrointestinal symptoms in autism spectrum disorderBradley J Ferguson, Sarah Marler, Lily L Altstein, et al.
Contemporary Clinical Trials|July 6, 2024
Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease: The FIRE-UP PD studyJuliana M Ison, Jonathan D Jackson, Helen Hemley, et al.
Neurology|February 26, 2016
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progressionMichael D Weiss, Eric A Macklin, Zachary Simmons, et al.
Pediatrics|February 25, 2022
Parent Training for Dental Care in Underserved Children With Autism: A Randomized Controlled TrialRachel M Fenning, Eric M Butter, Eric A Macklin, et al.
Lancet (London, England)|March 4, 2014
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trialAnne-Marie Wills, Jane Hubbard, Eric A Macklin, et al.
Neurology|September 6, 2019
Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trialMichael A Schwarzschild, Eric A Macklin, Rachit Bakshi, et al.
The Lancet. Neurology|April 2, 2013
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man studyTimothy M Miller, Alan Pestronk, William David, et al.
Psycho-Oncology|July 18, 2025
Psychosocial and NF-κB Activity Effects of the Stress Management and Resiliency Training: Relaxation Response Resiliency Program (SMART-3RP) on Patients With MGUS and Smoldering Multiple Myeloma: A Randomized Waitlist Control TrialLucy Finkelstein-Fox, John W Denninger, Leah E Walsh, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 15, 2019
Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosisSuma Babu, Eric A Macklin, Katherine E Jackson, et al.
Pageof 20

Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
Ebiomedicine|September 13, 2024
Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysisMichael Benatar, Eric A Macklin, Andrea Malaspina, et al.
Brain, Behavior, and Immunity|May 17, 2016
Associations between cytokines, endocrine stress response, and gastrointestinal symptoms in autism spectrum disorderBradley J Ferguson, Sarah Marler, Lily L Altstein, et al.
Contemporary Clinical Trials|July 6, 2024
Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease: The FIRE-UP PD studyJuliana M Ison, Jonathan D Jackson, Helen Hemley, et al.
Neurology|February 26, 2016
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progressionMichael D Weiss, Eric A Macklin, Zachary Simmons, et al.
Pediatrics|February 25, 2022
Parent Training for Dental Care in Underserved Children With Autism: A Randomized Controlled TrialRachel M Fenning, Eric M Butter, Eric A Macklin, et al.
Lancet (London, England)|March 4, 2014
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trialAnne-Marie Wills, Jane Hubbard, Eric A Macklin, et al.
Neurology|September 6, 2019
Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trialMichael A Schwarzschild, Eric A Macklin, Rachit Bakshi, et al.
The Lancet. Neurology|April 2, 2013
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man studyTimothy M Miller, Alan Pestronk, William David, et al.
Psycho-Oncology|July 18, 2025
Psychosocial and NF-κB Activity Effects of the Stress Management and Resiliency Training: Relaxation Response Resiliency Program (SMART-3RP) on Patients With MGUS and Smoldering Multiple Myeloma: A Randomized Waitlist Control TrialLucy Finkelstein-Fox, John W Denninger, Leah E Walsh, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 15, 2019
Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosisSuma Babu, Eric A Macklin, Katherine E Jackson, et al.
Pageof 20